TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04950413

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional physical therapy program
Description: Infrared, Exercises, Stretching exercise of Suboccepital muscle

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional physical therapy program
Description: Infrared, Exercises, Stretching exercise of Suboccepital muscle

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional physical therapy program
Description: Infrared, Exercises, Stretching exercise of Suboccepital muscle

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional physical therapy program
Description: Infrared, Exercises, Stretching exercise of Suboccepital muscle

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: IASTM by M2t blade
Description: A lubricant (Vaseline) will be applied to the skin around the neck area prior to treatment and the M2t blade will be cleaned with an alcohol pad. First, the M2T blade will used to ﬁnd the exact areas of restriction in affected muscles. Then the M2T blade will use at an angle of 45 to apply slow strokes along the muscle. Changes in soft tissue consistency will detected by the clinician through vibrations of the instrument when it slides on areas of irregular fibrosis of the underneath connective tissue. Once an adhesion is discovered, strokes are repeated for 5 min.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: IASTM by M2t blade
Description: A lubricant (Vaseline) will be applied to the skin around the neck area prior to treatment and the M2t blade will be cleaned with an alcohol pad. First, the M2T blade will used to ﬁnd the exact areas of restriction in affected muscles. Then the M2T blade will use at an angle of 45 to apply slow strokes along the muscle. Changes in soft tissue consistency will detected by the clinician through vibrations of the instrument when it slides on areas of irregular fibrosis of the underneath connective tissue. Once an adhesion is discovered, strokes are repeated for 5 min.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Phonophoresis
Description: It will be consisted of 1 MHz pulsed mode with an intensity set at 1.5 W/cm2 and. A 5 cm2 crystal head with an effective radiating area of 4.0 cm2 ±1.0 wills utilized for 5 Min for each trigger point of neck. lidocine gelwill applied instead of coupling US gel used for transmission.
Study: NCT05491551

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Treatment-Regulation of Craving
Description: Participants will be trained in using the MBT-based mindfulness strategy as described above (notice craving and accept the feeling without judgment or reaction). Participants will then be instructed to think of accepting and non-reactive responses when they see the instruction ACCEPT during ROC-T. On each trial, participants will receive an instruction and then be exposed to a novel alcohol image for 6 seconds. On 25% of the trials, they will see the LOOK instruction, and be allowed to experience craving (as baseline). On 75% of the trials, participants will see ACCEPT and then practice thinking about the negative consequences of drinking. After the picture disappears, they will rate their craving on every trial using a 1-5 Likert scale.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive-Based Therapy-Regulation of Craving
Description: Participants will be trained in using the CBT strategy by first considering and reading about the negative consequences of drinking. Participants will then be instructed to think of those negative consequences (Focus on the negative consequences associated with drinking) when they see the instruction REFRAME during ROC-T.On each trial, participants will receive an instruction and then be exposed to a novel alcohol image for 6 seconds. On 25% of the trials, they will see the LOOK instruction, and be allowed to experience craving (as baseline). On 75% of the trials, participants will see REFRAME and then practice thinking about the negative consequences of drinking. After the picture disappears, they will rate their craving on every trial using a 1-5 Likert scale
Study: NCT06080269

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: technology based intervention along with conventional therapy
Description: Technology based intervention are training session given to the participants through devices which has software installed to train cognitive functions for patients with cognitive deficit.
Study: NCT04950413

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Phonophoresis
Description: It will be consisted of 1 MHz pulsed mode with an intensity set at 1.5 W/cm2 and. A 5 cm2 crystal head with an effective radiating area of 4.0 cm2 ±1.0 wills utilized for 5 Min for each trigger point of neck. lidocine gelwill applied instead of coupling US gel used for transmission.
Study: NCT05052879

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Toronto association
Description: Toronto association coated tablet, 20 mg + 30 mg or 20 mg + 60 mg, oral, 2 hours before the sexual intercourse.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tadalafil
Description: Tadalafil coated tablet, 20 mg, oral, 2 hours before the sexual intercourse.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tadalafil placebo
Description: Tadalafil placebo coated tablet, oral, 2 hours before the sexual intercourse.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Toronto association placebo
Description: Toronto association placebo coated tablet, oral, 2 hours before the sexual intercourse.
Study: NCT06498817

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard Recommendation
Description: Standard recommendation given by government of Bangladesh on the use of oral rehydration solution (ORS) and a flyer on water treatment and handwashing with soap given at the health facility during the time of diarrhea patient treatment.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Recommendation
Description: Standard recommendation given by government of Bangladesh on the use of oral rehydration solution (ORS) and a flyer on water treatment and handwashing with soap given at the health facility during the time of diarrhea patient treatment.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CHoBI7 Scale-Up Program
Description: Health promoter delivery of handwashing with soap, water treatment, and safe water storage module in the health facility to diarrhea patients and the patient's household members during the time of treatment. This module includes video testimonials from diarrhea patient households on how the patient benefits from adhering to the promoted behaviors, and a demonstration on how to construct homemade handwashing washing stations. This in-person module is reinforced by weekly voice, interactive voice response, and text messages for three months sent to the mobile phones of diarrhea patient household members from a doctor at diarrhea ward at local hospital.
Study: NCT06568445

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Maintenance at initial treatment sequential as-needed therapy with inhaled budesonide-formoterol(Symbicort 160/4.5) ®）
Description: one inhalation twice daily for 4 weeks maintenance, sequential as-needed for symptom relief (no more than 8 inhalations per day) to 24-week.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: as-needed therapy with inhaled budesonide-formoterol (Symbicort 160/4.5) ®）
Description: as-needed for symptom relief (no more than 8 inhalations per day) to 24-week.
Study: NCT04461080

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Community Health Worker
Description: Trained Community Health Worker

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Community Health Worker
Description: Trained Community Health Worker
Study: NCT04832555

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Non elective radiotherapy
Description: Simultaneous integrated boost on CTV volumes, delineated as per guidelines, with the exception of intermediate-low risk, where the CTVs are experimental.
Study: NCT06576830

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Methadone
Description: Single-dose intraoperative intravenous methadone with initial dose at 0.15 mg/kg in children and 0.2 mg/kg in adolescents.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fentanyl/Hydromorphone
Description: Per routine care, given as needed
Study: NCT06251024

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: RSV vaccine candidate
Description: Pharmaceutical form:Suspension for injection-Route of administration:Intramuscular Injection

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Pharmaceutical form:Suspension for injection-Route of administration:Intramuscular Injection
Study: NCT06103864

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dato-DXd
Description: Provided in 100mg vials. IV infusion. Experimental drug.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dato-DXd
Description: Provided in 100mg vials. IV infusion. Experimental drug.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Durvalumab
Description: Provided in 500mg vials. IV infusion. Experimental drug.
Study: NCT04243824

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gallium 68 Macro-aggregated albumin
Description: The radiotracer, Ga-68 MAA, will be administered prior to PET/MRI scan.
Study: NCT06103864

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Paclitaxel
Description: IV infusion. Active comparator.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nab-paclitaxel
Description: IV infusion. Active comparator.
Study: NCT04986618

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: One-way Nordic Exercise
Description: Participants in this group will be given the standard Nordic Hamstring exercise.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Two-way Nordic Exercise
Description: In addition to the standard Nordic Hamstring exercise, participants in this group will do the same exercise backwards for the quadriceps.
Study: NCT06103864

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gemcitabine
Description: IV infusion. Active comparator.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carboplatin
Description: IV infusion. Active comparator.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pembrolizumab
Description: IV infusion. Active comparator.
Study: NCT06220513

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: erector spinae plane block (ESP)
Description: patients will receive Ultrasound-guided erector spinae plane block (ESP) block for postoperative analgesia of adult patients undergoing laparoscopic appendectomy.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: transversus abdominis plane block(TAP)
Description: patients will receive Ultrasound-guided transversus abdominis plane block(TAP) Block for postoperative analgesia of adult patients undergoing laparoscopic appendectomy.
Study: NCT06362304

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: 99mTc-CNDG SPECT/CT
Description: FDG-PET and 99mTc-CNDG will be performed within 2 weeks before surgery.
Study: NCT05351216

Intervention type: OTHER
Description: No intervention

Intervention type: OTHER
Description: No intervention
Study: NCT06262490

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Traditional ultrasound therapy
Description: Ultrasound therapy for 2 session per week for until completing 12 treatment sessions (six weeks) with frequencies up to 3 MHz are used clinically to promote healing

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Traditional ultrasound therapy
Description: Ultrasound therapy for 2 session per week for until completing 12 treatment sessions (six weeks) with frequencies up to 3 MHz are used clinically to promote healing

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pelvic floor rehabilitation
Description: Pelvic floor rehabilitation for 3 sessions per week for (six weeks) until completing 18 sessions with sessions lasting between 30-45 minutes
Study: NCT04308759

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental Smoking Cessation Program
Description: Participate in Quitbot experimental cessation program

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control Smoking Cessation Program
Description: Participate in Quitbot control cessation program
Study: NCT05188287

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HealthyCells
Description: Smoking cessation smartphone app
Study: NCT04967989

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Low Energy SLT
Description: SLT performed at low energy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Low Energy SLT
Description: SLT performed at low energy

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Low Energy SLT
Description: SLT performed at low energy

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard Energy SLT
Description: SLT performed at standard energy

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard Energy SLT
Description: SLT performed at standard energy
Study: NCT05012098

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bintrafusp alfa / M7824
Description: Participants will be treated with bintrafusp alfa 1200 mg every 2 weeks for 26 doses.
Study: NCT06458023

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TetraGraph (TM) NMT Monitor
Description: TetraGraph is a unique, EMG-based portable device for quantitative (objective) monitoring of neuromuscular function. It is a precise and easy to use tool for monitoring depth of block, ensuring adequate recovery of muscle function, and aiding the clinician to reduce the incidence of residual block.
Study: NCT05855473

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Auricular acupuncture
Description: The NADA protocol used in this study uses five specific points on the ear: Shen men, sympathetic autonomic, lung, liver, and kidney. Using this protocol, semi-permanent needles and seeds were placed unilaterally at five specific points in the ear by a specialist physician certified in acupuncture.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Auricular acupuncture
Description: The NADA protocol used in this study uses five specific points on the ear: Shen men, sympathetic autonomic, lung, liver, and kidney. Using this protocol, semi-permanent needles and seeds were placed unilaterally at five specific points in the ear by a specialist physician certified in acupuncture.
Study: NCT06269614

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Probiotic
Description: Consumption of probiotic with parent- as tolerated for 4 weeks.
Study: NCT04309760

Intervention type: OTHER
Group type: OTHER
Intervention: MRI
Description: Subjects will receive structural and functional (resting state) MRI

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: MRI
Description: Subjects will receive structural and functional (resting state) MRI
Study: NCT05314413

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Single Leg Immobilization
Description: 7-days of single leg immobilization to induce muscle atrophy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Single Leg Immobilization
Description: 7-days of single leg immobilization to induce muscle atrophy
Study: NCT06330545

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation therapy
Description: Patients with Dupuytren's Contacture will undergo Collagenase Clostridium Histolyticum injection and release followed by two 5-day courses of radiation therapy separated by 6-8 weeks. They will then be followed for 3 years for recurrence.
Study: NCT06372834

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: piTBS being delivered using the Magstim Rapid2 stimulator
Description: Magstim Rapid2 stimulator (Magstim Company, Ltd, Whitland, Wales, UK, SA340HR). See detail in arm/group descriptions regarding the intervention.
Study: NCT05692232

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional intervention
Description: A hot pads was applied for 20minutes underneath the cervical spine covering either side of shoulder in a relaxed supine position.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional intervention
Description: A hot pads was applied for 20minutes underneath the cervical spine covering either side of shoulder in a relaxed supine position.
Study: NCT06372834

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: piTBS being delivered using the Magstim Rapid2 stimulator
Description: Magstim Rapid2 stimulator (Magstim Company, Ltd, Whitland, Wales, UK, SA340HR). See detail in arm/group descriptions regarding the intervention.
Study: NCT05447559

Intervention type: DRUG
Group type: OTHER
Intervention: Cefazolin
Description: Intravenous administration of 2 g cefazolin

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cefazolin
Description: Intravenous administration of 2 g cefazolin

Intervention type: DRUG
Group type: OTHER
Intervention: Water for injection
Description: Intravenous administration of 10mL sterile water for injection
Study: NCT05176327

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Exoskeleton training with Ekso NR
Description: Walking exercise with Ekso NR

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Exoskeleton training with Ekso NR
Description: Walking exercise with Ekso NR
Study: NCT05447559

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Water for injection
Description: Intravenous administration of 10mL sterile water for injection
Study: NCT06192264

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: ASC40
Description: ASC 40 tablets orally once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ASC40
Description: ASC 40 tablets orally once daily
Study: NCT06318091

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: platelet poor plasma gel
Description: injection of platelet poor plasma gel in the dark circles around the eye to rejuvenate and improve pigmentation

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: nanofat
Description: injection of nanofat in the dark circles around the eye to rejuvenate and improve pigmentation
Study: NCT05508321

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Nasal brushing
Description: Nasal brushing to harvest nasal cells and perform staining experiments

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Nasal brushing
Description: Nasal brushing to harvest nasal cells and perform staining experiments

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Sniffin' Sticks
Description: Assessment of olfactory function

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Sniffin' Sticks
Description: Assessment of olfactory function
Study: NCT05234099

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: 18F-FDG Positron emission tomography - MRI
Description: All the examinations will be performed in the supine position on the same integrated 3T PET-MRI scanner

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Multiparametric ultrasound imaging
Description: Acquisitions of respiratory muscles (diaphragm, intercostal muscles) will be performed using two 6 MHz central frequency linear transducer (SL 10-2) driven by two identical ultrafast ultrasound devices.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Surface electromyography
Description: sEMG recordings will be performed in the left side on the sternocleidomastoid muscle, the intercostal parasternal muscle, and the external oblique muscle using pairs of 20-mm-diameter silver chloride surface electrodes.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Transdiaphragmatic preasure measurmement
Description: Esophageal and gastric pressures will be measured using 8-cm balloon-catheters.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Magnetic stimulation of the phrenic nerves
Description: In order to quantify the contractile fatigue in diaphragm induced by the ventilatory task (described below), we will use bilateral anterior magnetic stimulation of the phrenic nerves using two Magstim 200 stimulator.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Ventilation against inspiratory loading
Description: A POWERbreathe KH2 device (POWERbreathe International Ltd) will be connected on the inspiratory side of the two-way valve. Level of inspiratory loading will be randomized in order to produce different amounts of muscle work in each subject.
Study: NCT05465044

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Twice-weekly hemodialysis with incremental crossover to thrice-weekly schedule
Description: 50% of the eligible participants will be assigned to twice-weekly hemodialysis for up to 12 months with incremental crossover to thrice-weekly hemodialysis as indicated.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Thrice-Weekly Hemodialysis
Description: 50% of the eligible participants will be assigned to outright thrice-weekly hemodialysis, which will be continuation of the initial thrice-weekly schedule during the run-in period, without the option to switch to less frequent dialysis schedule representing the standard of care.
Study: NCT06072612

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SV-BR-1-GM
Description: SV-BR-1-GM is an experimental, allogeneic, whole cell breast tumor cell line stably transfected with the CSF2 gene (encoding GM-CSF) to secrete GM-CSF in vivo to consequently augment dendritic cell activity
Study: NCT05134727

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD5055
Description: Healthy participants will receive AZD5055